MUC1 peptide epitopes associated with five different H-2 class I molecules

被引:67
作者
Apostolopoulos, V
Haurum, JS
McKenzie, IFC
机构
[1] AUSTIN RES INST,HEIDELBERG,VIC 3084,AUSTRALIA
[2] DANISH CANC SOC,DEPT TUMOR CELL BIOL,COPENHAGEN,DENMARK
关键词
mucin; 1; epitope; major histocompatibility complex class I; peptide;
D O I
10.1002/eji.1830271017
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have previously described the induction of murine CD8(+) major histocompatibility complex (MHC) class I-restricted cytotoxic T cells (CTL) recognizing the 20-amino acid repeat region of the human mucin 1 (MUC1) variable number of tandem repeats region (VNTR), a mucin greatly increased in expression in breast cancer and proposed as a target for immunotherapy. In that study, CTL could detect MUC1 peptides associated with the MHC of all nine strains examined, and we now report the different epitopes presented by five different MHC class I molecules. The epitopes were defined in CTL assays using peptide-pulsed phytohemagglutinin blasts or MHC class I-transfected L cells as targets; in addition, peptide binding assays and T cell proliferation studies were performed. Within the 20-amino acid VNTR, nine potential epitopes could be defined. The epitopes for the four MHC class I molecules [K-b (three epitopes), D-d, L-d and K-k] were closely related, all containing the amino acids PDTRPAP. For D-b, three epitopes were identified, all containing APGSTAP. Most of the epitopes did not contain a consensus motif for the particular MHC class I allele, and bound with low 'affinity', compared with known high-affinity peptides. CD8(+) T cell proliferation also occurred to the same MHC class I-presented epitopes. Finally, when conventional anchor residues were introduced into the peptides, peptide binding increased, whereas CTL recognition was either retained (K-b) or lost (D-b) depending on the epitope.
引用
收藏
页码:2579 / 2587
页数:9
相关论文
共 40 条
[1]   VACCINIA VIRUS MUC1 IMMUNIZATION OF MICE - IMMUNE-RESPONSE AND PROTECTION AGAINST THE GROWTH OF MURINE TUMORS BEARING THE MUC1 ANTIGEN [J].
ACRES, RB ;
HAREUVENI, M ;
BALLOUL, JM ;
KIENY, MP .
JOURNAL OF IMMUNOTHERAPY, 1993, 14 (02) :136-143
[2]  
APOSTOLOPOULOS V, 1994, CANCER RES, V54, P5186
[3]   Breast cancer immunotherapy: Current status and future prospects [J].
Apostolopoulos, V ;
McKenzie, IFC ;
Pietersz, GA .
IMMUNOLOGY AND CELL BIOLOGY, 1996, 74 (05) :457-464
[4]   PRODUCTION OF ANTI-BREAST CANCER MONOCLONAL-ANTIBODIES USING A GLUTATHIONE-S-TRANSFERASE-MUC1 BACTERIAL FUSION PROTEIN [J].
APOSTOLOPOULOS, V ;
XING, PX ;
TRAPANI, JA ;
MCKENZIE, IFC .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :713-720
[5]   Cell-mediated immune responses to MUC1 fusion protein coupled to mannan [J].
Apostolopoulos, V ;
Pietersz, GA ;
McKenzie, IFC .
VACCINE, 1996, 14 (09) :930-938
[6]   OXIDATIVE REDUCTIVE CONJUGATION OF MANNAN TO ANTIGEN SELECTS FOR T-1 OR T-2 IMMUNE-RESPONSES [J].
APOSTOLOPOULOS, V ;
PIETERSZ, GA ;
LOVELAND, BE ;
SANDRIN, MS ;
MCKENZIE, IFC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10128-10132
[7]  
APOSTOLOPOULOS V, 1995, J IMMUNOL, V155, P5089
[8]   SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS [J].
BARND, DL ;
LAN, MS ;
METZGAR, RS ;
FINN, OJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7159-7163
[9]   CHARACTERIZATION OF THE L(D)-RESTRICTED CYTOTOXIC T-LYMPHOCYTE EPITOPE IN THE MOUSE HEPATITIS-VIRUS NUCLEOCAPSID PROTEIN [J].
BERGMANN, C ;
MCMILLAN, M ;
STOHLMAN, S .
JOURNAL OF VIROLOGY, 1993, 67 (12) :7041-7049
[10]   THE FOREIGN ANTIGEN-BINDING SITE AND T-CELL RECOGNITION REGIONS OF CLASS-I HISTOCOMPATIBILITY ANTIGENS [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :512-518